AVE-8680

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAVE-8680
Drug Alias NameAVE-8680
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInhibitor of nuclear factor kappa-B kinase subunit beta inhibitors
TargetsInhibitor of nuclear factor kappa-B kinase subunit beta
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMillennium Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiMillennium Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A